Olivier Soula – Bourse et Valeurs, Lyon Pole Bourse 2024 (FR)
10/30/2024 ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update Icon check
10/15/2024 ADOCIA announces patenting stable combinations of GLP-1 and amylin analogs for the treatment of obesity and diabetes using its BioChaperone® platform Icon check
10/08/2024 Number of Shares and Voting Rights of ADOCIA as of September 30th, 2024 Icon check
09/23/2024 ADOCIA Announces Appointment of Mathieu William Gilbert as Chief Financial Officer Icon check
09/20/2024 Number of Shares and Voting Rights of ADOCIA as of August 31st, 2024 Icon check
09/19/2024 ADOCIA Announces First Half 2024 Financial Results and Provides a Business Update Icon check
08/30/2024 Number of Shares and Voting Rights of ADOCIA as of July 31st, 2024 Icon check
08/29/2024 ADOCIA to Deliver Oral Presentations on AdoShell® and AdoGel® at EASD Annual Meeting Icon check
07/24/2024 ADOCIA Reports Second Quarter 2024 Financial Results and Provides a Business Update Icon check
07/19/2024 ADOCIA Announces Half year report on Adocia’s liquidity agreement with Kepler Capital Markets Icon check
07/11/2024 Number of Shares and Voting Rights of ADOCIA as of June 30th, 2024 Icon check
Web Conference – BioChaperone Combo – July 2024 (FR)
07/10/2024 ADOCIA Announces that Tonghua Dongbao is Discontinuing one of the two Partnership Programs: BioChaperone® Combo Icon check
06/18/2024 ADOCIA Announces Three Presentations at the American Diabetes Association 84th Scientific Sessions Icon check
06/17/2024 Number of Shares and Voting Rights of ADOCIA as of May 31 st, 2024 Icon check
06/06/2024 ADOCIA confirms its eligibility for the PEA–PME Icon check
06/03/2024 ADOCIA Announces Appointment of Mathieu William Gilbert as Chief Operating Officer Icon check
Interview Olivier Soula – La France de Demain, Radio Classique – May 2024 (FR)
05/23/2024 ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 13th, 2024 in Paris Icon check
05/15/2024 Number of shares and voting rights of ADOCIA as of April 30th, 2024 Icon check
05/14/2024 ADOCIA Reports First Quarter 2024 Financial Results and Provides a Business Update Icon check
Olivier Soula – LSX World Congress – April 2024
05/03/2024 Investor Presentation – LSX World Congress – April 2024 Icon check
04/29/2024 ADOCIA Announces the Release of its Universal Registration Document for the Year 2023 Icon check
04/24/2024 ADOCIA Announces Full Year 2023 Financial Results and Provides a Corporate and Financial Update Icon check
04/12/2024 Number of shares and voting rights of ADOCIA as of March 31st, 2024 Icon check
Interview Olivier Soula – Le Journal des Biotechs – March 2024 (FR)
03/21/2024 ADOCIA Announces a €2 Million Fundraising from its two Main Shareholders and a Member of its Management, and the Signature of an Equity Financing Line with Vester Finance Icon check
BIO-Europe Spring 2024: Interview with Jérémy Benattar
03/15/2024 Number of shares and voting rights of ADOCIA as of February 29th, 2024 Icon check
03/06/2024 ADOCIA Announces Its Participation at Key Events Icon check
Web-conference – 4th Quarter 2023 Financial Results (FR)
02/29/2024 Web-conference – Financial Results – 2023 Fourth Quarter (French) Icon check
02/27/2024 ADOCIA Reports Fourth Quarter 2023 Financial Results and Provides a Business Update Icon check
02/13/2024 Number of shares and voting rights of ADOCIA as of January 31st, 2024 Icon check
01/25/2024 ADOCIA Announces its Financial Calendar for 2024 Icon check
01/17/2024 ADOCIA Announces Half year report on Adocia’s liquidity agreement with Kepler Capital Markets Icon check
01/16/2024 Number of shares and voting rights of ADOCIA as of December 31st, 2023 Icon check
01/10/2024 ADOCIA – Investor Presentation – Biotech Showcase/JPM24 – January 2024 Icon check
Olivier Soula – Le Revenu TV – Dec. 2023 (FR)
Web conférence – Diabète : un laboratoire pour le futur de la santé – déc. 2023 (FR)
12/15/2023 Number of shares and voting rights of ADOCIA as of November 30th, 2023 Icon check
11/28/2023 ADOCIA – Investir Day – Nov 2023 (FR) Icon check
11/23/2023 Letter to Shareholders – November 2023 Icon check
Olivier Soula – Investival Showcase
11/15/2023 Number of shares and voting rights of ADOCIA as of October 31st, 2023 Icon check
11/13/2023 ADOCIA – LSX Investival Presentation – Nov 2023 Icon check
11/09/2023 ADOCIA Revealed Promising Preclinical Data on AdoShell® Islets for Cell Therapy of Diabetes Icon check
10/25/2023 ADOCIA Reports Financial Results of Third Quarter 2023 and Provides an Update on its Activities Icon check
Join our mailing list. Subscribe